Xponential Fitness Reports Mixed Q4 2025 Results; Shares Tumble on Cautious Outlook
Xponential Fitness Inc-A (NYSE:XPOF), a leading franchisor of boutique fitness brands, delivered a fourth-quarter financial performance that surpassed analyst expectations on the top line but revealed deeper losses and a significantly softer outlook for the year ahead, sending its stock sharply lower in after-hours trading.
Earnings and Revenue Versus Estimates
The company’s reported figures for the final quarter of 2025 presented a stark contrast between a revenue beat and a substantial miss on profitability.
- Revenue: Xponential posted Q4 revenue of $83.0 million, essentially flat compared to the $83.3 million reported in the prior-year period. This result, however, came in well ahead of the analyst consensus estimate of approximately $74.9 million.
- Earnings Per Share: The bottom line told a different story. The company reported an adjusted net loss per share of $0.91, a significant deviation from the analyst estimate for a loss of $0.0221. This compares to an adjusted net loss of $0.19 per share in Q4 2024.
While the revenue outperformance suggests underlying system sales strength, the wider-than-expected loss indicates considerable pressure on margins or one-time costs impacting profitability.
Market Reaction and Forward Guidance
The market’s reaction was decisively negative, with shares falling approximately 18.6% in after-market trading following the release. This sharp decline appears to be primarily driven by the company’s guidance for the full 2026 fiscal year, which fell meaningfully short of Wall Street’s expectations.
Xponential provided an initial outlook for 2026 that calls for:
- Revenue in the range of $260 million to $270 million (a midpoint of $265 million).
- Adjusted EBITDA between $100 million and $110 million.
This revenue guidance midpoint of $265 million represents a 16% decrease from 2025 results and, more critically, is about 14% below the current analyst consensus estimate of approximately $308.8 million for 2026 sales. The projected slowdown in net new studio openings and a modest 1% midpoint increase in North America system-wide sales further signal a period of deliberate consolidation rather than aggressive growth.
Key Elements from the Press Release
Beyond the headline numbers, the earnings release highlighted several important operational and financial developments:
- Full-Year 2025 Results: For the full year, revenue decreased 2% to $314.9 million. Adjusted EBITDA declined 4% to $111.8 million, and the company posted an adjusted net loss of $18.4 million.
- System-Wide Sales Growth: A bright spot was the 13% increase in full-year North America system-wide sales to $1.75 billion, though same-store sales growth slowed to 0.5% from 7% in 2024.
- Regulatory and Legal Settlements: The company announced progress on resolving significant overhangs, including a potential $17 million settlement with the FTC and a finalized $22.75 million settlement with a large group of franchisees. Management believes these actions will "substantially reduce regulatory and legal uncertainty."
- Balance Sheet and Liquidity: As of December 31, 2025, Xponential held approximately $45.9 million in cash against $525 million in total long-term debt. Net cash provided by operating activities for the year was $28.3 million.
CEO Mike Nuzzo framed 2025 as a year of strategic refinement, stating the company is now focused on "driving organic growth and elevating the member experience," even if that requires investments that result in "more modest near-term Adjusted EBITDA."
Conclusion
Xponential Fitness’s Q4 report paints a picture of a company in transition. While it exceeded revenue estimates for the quarter, the larger-than-expected loss and, most importantly, a 2026 guidance forecast that is significantly below analyst projections have unsettled investors. The market’s negative reaction reflects concerns over the near-term growth trajectory and profitability as the company navigates legal settlements and shifts its strategic focus towards studio-level health over pure unit expansion. The coming quarters will be critical in demonstrating whether this recalibration can lead to more sustainable and profitable growth.
For a detailed look at historical earnings, future estimates, and analyst projections, you can review the data here.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, a recommendation, or an offer or solicitation to buy or sell any securities. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.